Background: Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and lower respiratory tract infections in children in their first year of life, disproportionately affecting infants in developing countries. Previous studies have found that the nasopharyngeal (NP) microbiome of infants with RSV infection has specific characteristics that correlate with disease severity, including lower biodiversity, perturbations of the microbiota and differences in relative abundance. These studies have focused on infants seen in clinical or hospital settings, predominantly in developed countries.
Methods: We conducted a nested case control study within a random sample of 50 deceased RSV+ infants with age at death ranging from 4 days to 6 months and 50 matched deceased RSV- infants who were all previously enrolled in the Zambia Pertussis and RSV Infant Mortality Estimation (ZPRIME) study. All infants died within the community or within 48 hours of facility admittance. As part of the ZPRIME study procedures, all decedents underwent one-time, postmortem NP sampling. The current analysis explored the differences between the NP microbiome profiles of RSV+ and RSV- decedents using the 16S ribosomal DNA sequencing.
Results: We found that Moraxella was more abundant in the NP microbiome of RSV+ decedents than in the RSV- decedents. Additionally, Gemella and Staphylococcus were less abundant in RSV+ decedents than in the RSV- decedents.
Conclusions: These results support previously reported findings of the association between the NP microbiome and RSV and suggest that changes in the abundance of these microbes are likely specific to RSV and may correlate with mortality associated with the disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348642 | PMC |
| http://dx.doi.org/10.1097/INF.0000000000003941 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microbial Dysbiosis in Nasopharyngeal Carcinoma: A Pilot Study on Biomarker Potential.
J Otolaryngol Head Neck Surg
December 2024
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Importance: Nasopharyngeal carcinoma (NPC) is closely linked to microorganisms, especially intra-tumoral microbiota. However, the role of commensal microbiota in NPC remains underexplored, with implications for understanding disease mechanisms.
Objective: This study aims to analyze and compare the bacterial microbiota in the nasopharynx and middle meatus (MM) of individuals with NPC and those without NPC.
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in children.
Cell Rep Med
December 2024
Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, the Netherlands; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. Electronic address:
Respiratory syncytial virus (RSV) is the leading cause of infant respiratory infections and hospitalizations. To investigate the relationship between the respiratory microbiome and RSV infection, we sequence nasopharyngeal samples from a birth cohort and a pediatric case-control study (Respiratory Syncytial virus Consortium in Europe [RESCEU]). 1,537 samples are collected shortly after birth ("baseline"), during RSV infection and convalescence, and from healthy controls.
View Article and Find Full Text PDFPembrolizumab (MK-3475) plus platinum and gemcitabine as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (PIPER): a phase 2, multicentre, single-arm protocol study in Malaysia.
BMJ Open
December 2024
Clinical Oncology Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
Article Synopsis
- The study aims to evaluate the effectiveness of combining pembrolizumab with platinum and gemcitabine (PG) as a first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in Malaysia, comparing it to the existing treatment with pembrolizumab plus platinum and 5-fluorouracil (PF).
- It is a phase 2, open-label, multicenter study enrolling up to 89 participants, where pembrolizumab will be administered alongside chemotherapy for six cycles, and various response and safety metrics will be assessed.
- The trial has received ethical approval and its results will be shared through conferences and scientific publications, aiming to contribute valuable findings to cancer treatment discussions.
Disentangling the molecular mystery of tumour-microbiota interactions: Microbial metabolites.
Clin Transl Med
November 2024
State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Article Synopsis
- The microbiota significantly influences cancer initiation and progression, with microbial metabolites connecting these two areas, though the detailed molecular mechanisms are still unclear.* -
- Various mechanisms, such as disrupting cell signaling and reshaping the tumor immune environment, are important in understanding how tumours develop and resist therapy.* -
- Current research highlights the critical roles of microbial metabolites in cancer, but challenges like the need for better quantification methods and integrating different research approaches still remain.*
Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
Ann Allergy Asthma Immunol
November 2024
Department of Infectious Diseases, The First Affiliated Hospital (Shenzhen People's Hospital), School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China. Electronic address:
Background: Airway microbiome has been linked to asthma heterogeneity, yet little is known about the associations between airway microbiota and type 2 (T2) asthma phenotype and severity.
Objective: To determine the relationship of nasopharyngeal (NP) and induced sputum (IS) microbiota to the phenotypic features of T2 asthma.
Methods: NP and IS samples from subjects with T2 mild-to-moderate asthma (n = 23), subjects with severe asthma (n = 21), and healthy controls (n = 16) were analyzed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!